A comprehensive systematic review and meta-analysis published in the Journal of Translational Medicine analyzed data from seven distinct studies encompassing over 400 patients
Repackaged products tend to lean on vague, sweeping promises 'supports your journey,' 'optimizes wellness' because vague claims are cheap and unfalsifiable
They affect approximately 1 in 10 people in the UK at some point in their lives, with men being more commonly affected than women
Methods: The study conducted extensive searches across various databases, including Cochrane Library, Web of Science, PubMed, Google Scholar, and Science Direct, to identify studies on IBS and related drugs
Mercks exposure to a successful pembrolizumab biosimilar after 2028 is the single largest revenue-at-risk event in the industry
W.hmanL.ClaessonM